Copyright
©The Author(s) 2019.
World J Hepatol. Apr 27, 2019; 11(4): 391-401
Published online Apr 27, 2019. doi: 10.4254/wjh.v11.i4.391
Published online Apr 27, 2019. doi: 10.4254/wjh.v11.i4.391
HS only | NAFLD | P value | NASH | P value | NAFL | P value | |
n | 51 | 32 | 12 | 20 | |||
Age, mean(SD) | 43.04 (8.9) | 41.32 (9.0) | 0.564 | 41.58 (7.4) | 0.602 | 40.55 (10.3) | 0.315 |
Age cat (%) | 0.646 | 0.463 | 0.629 | ||||
< 30 | 3 (5.9) | 4 (12.5) | 1 (8.3) | 3 (15.0) | |||
30-39 | 16 (31.4) | 8 (25.0) | 2 (16.7) | 6 (30) | |||
40-49 | 18 (35.3) | 14 (43.8) | 7 (58.3) | 7 (35.0) | |||
> 50 | 14 (27.5) | 6 (18.8) | 2 (16.7) | 4 (20.0) | |||
Male, n (%) | 17 (33.3) | 14 (43.8) | 0.623 | 5 (41.7) | 0.835 | 9 (45.0) | 0.52 |
Diabetes, n (%) | 12 (23.5) | 9 (28.1) | 0.853 | 3 (25.0) | 0.764 | 6 (30.0) | 0.794 |
BMI, mean(SD) | 28.31 (2.5) | 27.56 (1.9) | 0.381 | 27.58 (2.7) | 0.376 | 27.55 (1.7) | 0.218 |
bmi_cat (%) | 0.559 | 0.515 | 0.384 | ||||
Normal Weight | 4 (7.8) | 4 (12.5) | 2 (16.7) | 2 (10.0) | |||
Overweight | 38 (74.5) | 26 (81.3) | 9 (75.0) | 17 (85.0) | |||
Obese | 9 (17.6) | 2 (6.3) | 1 (8.3) | 1 (5.0) | |||
IHS4, mean(SD) | 9.57 (3.6) | 11.32 (2.8) | 0.025 | 12.67 (3.6) | 0.009 | 9.40 (3.9). | 0.861 |
IHS4 cat (%) | 0.028 | 0.007 | 0.97 | ||||
Mild | 5 (9.8) | 3 (9.4) | 1 (8.3) | 2 (10.0) | |||
Moderate | 24 (47.1) | 10 (31.3) | 0 (0) | 10 (50.0) | |||
Severe | 22 (43.1) | 19 (59.4) | 11 (91.7) | 8 (40) | |||
Hurley (%) | 0.494 | 0.197 | 0.785 | ||||
1 | 5 (9.8) | 3 (9.4) | 1 (8.3) | 2 (10.0) | |||
2 | 24 (47.1) | 6 (18.8) | 1 (8.3) | 5 (25.0) | |||
3 | 22 (43.1) | 23 (71.9) | 10 (83.3) | 13 (65.0) | |||
Elevated_liver_enzymes, n (%) | 19 (37.3) | 9 (28.1) | 0.617 | 4 (33.3) | 0.998 | 5 (25.0) | 0.482 |
ADDI_score, mean(SD) | 2.55 (1.4) | 3.72 (1.8) | < 0.001 | 5.33 (2.2) | < 0.001 | 2.75 (1.6) | 0.603 |
Inflammatory comorbidities, n (%) | 2 (3.9) | 12 (37.5) | < 0.001 | 7 (58.3) | < 0.001 | 5 (25.0) | 0.025 |
In detail (%) | 0.001 | < 0.001 | 0.047 | ||||
Acne conglobata | 1 (2.0) | 0 (0) | 0 (0) | 0 (0) | |||
Crohn disease | 0 (0) | 2 (6.3) | 1 (8.3) | 1 (5.0) | |||
Lichen sclerosus | 1 (2.0) | 0 (0) | 0 (0) | 0 (0) | |||
PASH | 0 (0) | 5 (15.6) | 4 (33.3) | 1 (5.0) | |||
Psoriasis | 0 (0) | 2 (6.3) | 1 (8.3) | 1 (5.0) | |||
Spondyloarthritis | 0 (0) | 2 (6.3) | 1 (8.3) | 1 (5.0) | |||
Uveitis | 0 (0) | 1 (3.1) | 0 (0) | 1 (5.0) | |||
Positive ultrasound, n (%) | 11 (21.6) | 32 (100.0) | < 0.001 | 12 (100.0) | < 0.001 | 20 (100.0) | < 0.001 |
NASH | 0 (0) | 12 (37.5) | < 0.001 | 12 (100.0) | 0 (0) | ||
NAFL | 0 (0) | 20 (62.5) | < 0.001 | 0 (0) | 20 (100.0) |
Non diabetes | Diabetes | P value | |
n | 62 | 21 | |
Age, mean(SD) | 42.44 (9.4) | 41.62 (8.2) | 0.722 |
Age cat (%) | 0.203 | ||
< 30 | 4 ( 6.5) | 3 (14.3) | |
> 50 | 17 (27.4) | 3 (14.3) | |
30-39 | 20 (32.3) | 4 (19.0) | |
40-49 | 21 (33.9) | 11 (52.4) | |
Male, n (%) | 21 (33.9) | 10 ( 47.6) | 0.387 |
Diabetes, n (%) | 0 ( 0.0) | 21 (100.0) | <0.001 |
BMI, mean(SD) | 28.10 (2.6) | 27.81 (1.4) | 0.636 |
bmi_cat (%) | 0.161 | ||
Normal Weight | 8 (12.9) | 0 ( 0.0) | |
Obese | 9 (14.5) | 2 ( 9.5) | |
Overweight | 45 (72.6) | 19 ( 90.5) | |
IHS4, mean(SD) | 10.37 (3.6) | 8.81 (4.1) | 0.101 |
IHS4 cat, n (%) | 0.051 | ||
Mild | 4 ( 6.5) | 4 ( 19.0) | |
Moderate | 23 (37.1) | 11 ( 52.4) | |
Severe | 35 (56.5) | 6 ( 28.6) | |
Hurley, n (%) | 0.022 | ||
1 | 4 ( 6.5) | 4 ( 19.0) | |
2 | 14 (22.6) | 9 ( 42.9) | |
3 | 44 (71.0) | 8 ( 38.1) | |
Elevated_liver_enzymes, n (%) | 21 (33.9) | 7 ( 33.3) | 1 |
ADDI_score, mean(SD) | 3.13 (1.8) | 2.62 (2.0) | 0.275 |
Inflammatory comorbidities, n (%) | 9 (14.5) | 5 ( 23.8) | 0.518 |
In.detail, n (%) | 0.563 | ||
53 (85.5) | 16 ( 76.2) | ||
Acne conglobata | 1 ( 1.6) | 0 ( 0.0) | |
Crohn | 1 ( 1.6) | 1 ( 4.8) | |
Lichen sclerosus | 0 ( 0.0) | 1 ( 4.8) | |
PASH | 4 ( 6.5) | 1 ( 4.8) | |
Psoriasis | 1 ( 1.6) | 1 ( 4.8) | |
Spondyloarthritis | 1 ( 1.6) | 1 ( 4.8) | |
Uveitis | 1 ( 1.6) | 0 ( 0.0) | |
Positive_ultrasound, n (%) | 31 (50.0) | 12 ( 57.1) | 0.754 |
NASH, n (%) | 9 (14.5) | 3 ( 14.3) | 1 |
NAFL, n (%) | 14 (22.6) | 6 ( 28.6) | 0.795 |
Disease, n (%) | 0.853 | ||
HS only | 39 (62.9) | 12 ( 57.1) | |
NAFL | 14 (22.6) | 6 ( 28.6) | |
NASH | 9 (14.5) | 3 ( 14.3) |
- Citation: Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019; 11(4): 391-401
- URL: https://www.wjgnet.com/1948-5182/full/v11/i4/391.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i4.391